The cluster is small in dollar terms and dominated by asset managers doubling tiny positions, suggesting low conviction. The largest seller (Russell Investments) exited a meaningful stake. Monitor next 10-Q for whether the goodwill impairment signals deeper operational issues and whether the Diabetes Health sale closes as expected.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 9 $7.35entry
- T+1 · 7d ago +5.03%α +5.40% · $7.72
- T+5 · 18h ago +5.17%α +6.86% · $7.73
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
How similar events traded
Executive Summary
11 institutional buyers accumulated $5.1M in net new AHCO positions during Q3 2026, while 2 sellers reduced by $1.9M. The buying cluster follows Q3 earnings that beat revenue consensus but included a large goodwill impairment and lowered free cash flow guidance. The cluster is dominated by asset managers doubling small positions; no insider buying corroborates the signal.
Key Financial Metrics
Institutional Positions
Net institutional flow: $5.1M
▲ Buyers (11)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Citigroup | DOUBLED | +735.9% | $2.8M | $2.2M |
| Barclays | DOUBLED | +1178.5% | $1.7M | $1.5M |
| Wolverine Asset Management | DOUBLED | +198.4% | $1.0M | $387.0K |
▼ Sellers (2)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| Russell Investments Group | TRIM | -71.9% | $2.2M | -$1.9M |
| Nisa Investment Advisors | TRIM | -61.9% | $23.0K | -$18.0K |
Key Facts
- 11 institutional buyers added $5.1M net; 2 sellers reduced $1.9M
- Top buyers: Citigroup ($2.2M increase), Barclays ($1.5M increase), Wolverine Asset Management ($387K increase)
- Largest seller: Russell Investments Group trimmed 71.9% of its position, reducing value by $1.9M
- Q3 2026 revenue of $745.6M beat $725.9M consensus, but GAAP net loss of $167.0M included $184.8M goodwill impairment
- Adjusted EBITDA of $141.9M declined 2.9% YoY; free cash flow guidance lowered to $50M-$75M
- No open-market insider buying during the quarter (confluence score 32/100, institutions only)
Financial Impact
Net institutional buying of $5.1M (buyers $8.0M total, sellers $1.9M total) represents approximately 0.5% of market cap
Risk Factors
- 13F data is 45+ days stale; positions may have been unwound since quarter-end
- Goodwill impairment and declining Adjusted EBITDA suggest fundamental headwinds
- No insider buying to corroborate institutional accumulation
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-AHCO-2026-Q3 |
Track record
20 reports on AHCO
6 of 7 bullish or bearish reports moved the stock their way by T+1. Best: +47.49% at T+60 after the Jul 2, 2026 report. 7 of 7 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $7.80 settles Nov 18
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $7.89 settles Nov 17
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $7.87 to $7.66 ▼ −2.67% −2.31% vs SPY
- Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Viewing Entry $7.35 to $7.72 ▲ +5.03% +5.40% vs SPY
- Nov 6, 202610d ago 144 Neutral 2/10 Entry $7.35 to $7.72 ▲ +5.03% +5.40% vs SPY
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $7.33 to $7.35 ▲ +0.27% −2.09% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 3/10 Entry $7.41 to $7.33 ▼ −1.08% −1.39% vs SPY
- Nov 3, 202613d ago 8-K Mixed 6/10 Entry $6.28 to $7.31 ▲ +16.40% +14.75% vs SPY
- Oct 29, 202619d ago Court Ruling Neutral 2/10 Entry $5.81 to $5.91 ▲ +1.72% +2.20% vs SPY
- Oct 13, 20264w ago SC 13G/A Bearish 4/10 Entry $6.33 to $6.25 ▲ +1.26% +0.18% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers